FI108041B - Menetelmä terapeuttisesti käyttökelpoisten oligomeerien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten oligomeerien valmistamiseksi Download PDF

Info

Publication number
FI108041B
FI108041B FI913298A FI913298A FI108041B FI 108041 B FI108041 B FI 108041B FI 913298 A FI913298 A FI 913298A FI 913298 A FI913298 A FI 913298A FI 108041 B FI108041 B FI 108041B
Authority
FI
Finland
Prior art keywords
formula
methylphenyl
process according
oligomer
oligomers
Prior art date
Application number
FI913298A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI913298A0 (fi
FI913298A (fi
Inventor
Alan D Cardin
Michael J Mullins
Richard L Jackson
Original Assignee
Dow Chemical Co
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co, Merrell Dow Pharma filed Critical Dow Chemical Co
Publication of FI913298A0 publication Critical patent/FI913298A0/fi
Publication of FI913298A publication Critical patent/FI913298A/fi
Application granted granted Critical
Publication of FI108041B publication Critical patent/FI108041B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/41—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
    • C07C309/42—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/51—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/12—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from polycarboxylic acids and polyhydroxy compounds
    • C08G63/16—Dicarboxylic acids and dihydroxy compounds
    • C08G63/18—Dicarboxylic acids and dihydroxy compounds the acids or hydroxy compounds containing carbocyclic rings
    • C08G63/19—Hydroxy compounds containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
    • C08G63/688—Polyesters containing atoms other than carbon, hydrogen and oxygen containing sulfur
    • C08G63/6884—Polyesters containing atoms other than carbon, hydrogen and oxygen containing sulfur derived from polycarboxylic acids and polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
    • C08G63/692—Polyesters containing atoms other than carbon, hydrogen and oxygen containing phosphorus
    • C08G63/6924—Polyesters containing atoms other than carbon, hydrogen and oxygen containing phosphorus derived from polycarboxylic acids and polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
    • C08G64/04—Aromatic polycarbonates
    • C08G64/06—Aromatic polycarbonates not containing aliphatic unsaturation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
    • C08G64/04—Aromatic polycarbonates
    • C08G64/06—Aromatic polycarbonates not containing aliphatic unsaturation
    • C08G64/08—Aromatic polycarbonates not containing aliphatic unsaturation containing atoms other than carbon, hydrogen or oxygen
    • C08G64/081—Aromatic polycarbonates not containing aliphatic unsaturation containing atoms other than carbon, hydrogen or oxygen containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
    • C08G64/04—Aromatic polycarbonates
    • C08G64/06—Aromatic polycarbonates not containing aliphatic unsaturation
    • C08G64/08—Aromatic polycarbonates not containing aliphatic unsaturation containing atoms other than carbon, hydrogen or oxygen
    • C08G64/083—Aromatic polycarbonates not containing aliphatic unsaturation containing atoms other than carbon, hydrogen or oxygen containing phosphorus
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/26—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from polyamines and polycarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/26—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from polyamines and polycarboxylic acids
    • C08G69/32—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from polyamines and polycarboxylic acids from aromatic diamines and aromatic dicarboxylic acids with both amino and carboxylic groups aromatically bound
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G71/00—Macromolecular compounds obtained by reactions forming a ureide or urethane link, otherwise, than from isocyanate radicals in the main chain of the macromolecule
    • C08G71/02—Polyureas

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyamides (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
FI913298A 1990-07-09 1991-07-08 Menetelmä terapeuttisesti käyttökelpoisten oligomeerien valmistamiseksi FI108041B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54978290A 1990-07-09 1990-07-09
US54978290 1990-07-09
US07/710,370 US5276182A (en) 1990-07-09 1991-06-10 Process for preparing polyurea oligomers
US71037091 1991-06-10

Publications (3)

Publication Number Publication Date
FI913298A0 FI913298A0 (fi) 1991-07-08
FI913298A FI913298A (fi) 1992-01-10
FI108041B true FI108041B (fi) 2001-11-15

Family

ID=27069228

Family Applications (2)

Application Number Title Priority Date Filing Date
FI913298A FI108041B (fi) 1990-07-09 1991-07-08 Menetelmä terapeuttisesti käyttökelpoisten oligomeerien valmistamiseksi
FI930066A FI930066A (fi) 1990-07-09 1993-01-08 Antiherpesvirus- och cytomegalovirusoligomerer

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI930066A FI930066A (fi) 1990-07-09 1993-01-08 Antiherpesvirus- och cytomegalovirusoligomerer

Country Status (27)

Country Link
US (9) US5276182A (fr)
EP (2) EP0467185B1 (fr)
JP (2) JP3442072B2 (fr)
KR (2) KR100208547B1 (fr)
CN (1) CN1051096C (fr)
AP (1) AP287A (fr)
AT (2) ATE172477T1 (fr)
AU (2) AU635850B2 (fr)
CA (2) CA2046491A1 (fr)
CZ (1) CZ288574B6 (fr)
DE (2) DE69129410T2 (fr)
DK (2) DK0538373T3 (fr)
EG (1) EG19652A (fr)
ES (2) ES2124695T3 (fr)
FI (2) FI108041B (fr)
HK (1) HK1009280A1 (fr)
HU (2) HU214876B (fr)
IE (1) IE912375A1 (fr)
IL (1) IL98761A (fr)
MX (1) MX9100123A (fr)
NO (2) NO302827B1 (fr)
NZ (1) NZ238847A (fr)
OA (1) OA10045A (fr)
PT (1) PT98255B (fr)
RU (1) RU2102406C1 (fr)
SK (1) SK283655B6 (fr)
WO (1) WO1992000749A1 (fr)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5670144A (en) * 1990-07-09 1997-09-23 Merrell Pharmaceuticals Inc. Anti-herpes virus and cytomegalovirus polyester oligomers
US5312837A (en) * 1991-01-29 1994-05-17 Genelabs Technologies, Inc. Method of treating viral infections with aryl macrocyclic compounds
ATE116637T1 (de) * 1991-02-05 1995-01-15 Merrell Dow Pharma Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
US5217469A (en) * 1992-01-27 1993-06-08 Moshe Dolev Rotary head spring-loaded tweezer hair removal device
EP0626945B1 (fr) * 1992-02-20 1998-04-22 Merrell Pharmaceuticals Inc. Derives d'acide sulfonique utilises dans le traitement de maladies virales
CA2135646A1 (fr) * 1992-05-11 1993-11-25 Kenneth G. Draper Methode et reagent permettant l'inhibition de la replication virale
US5972699A (en) * 1992-05-14 1999-10-26 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting herpes simplex virus replication
US5460807A (en) * 1992-08-19 1995-10-24 Merrell Dow Pharmaceuticals Inc. Antiproliferative oligomers
NZ254646A (en) * 1992-08-19 1997-06-24 Merrell Dow Pharma Inhibition of angiogenesis by administration of a polyamide and a polyurea
HUT70192A (en) * 1992-09-28 1995-09-28 Merrell Dow Pharma Method for antagonizing inositol 1,4,5-triphosphate
US5384119A (en) * 1993-08-12 1995-01-24 Merrell Dow Pharmaceuticals Inc. Method of preventing neutrophil mediated connective tissue damage
IL112174A (en) * 1994-01-03 1999-05-09 Merrell Dow Pharma Oligomers of polythioureas pharmaceutical compositions containing them and a process for their preparation
JPH11503110A (ja) 1995-02-17 1999-03-23 スミスクライン・ビーチャム・コーポレイション Ｉｌ−８受容体拮抗剤
US5780483A (en) * 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
US6005008A (en) * 1996-02-16 1999-12-21 Smithkline Beecham Corporation IL-8 receptor antagonists
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
PL330849A1 (en) 1996-06-27 1999-06-07 Smithkline Beecham Corp Antagonists of il-8 receptors
AU3409197A (en) * 1996-06-27 1998-01-14 Smithkline Beecham Corporation Il-8 receptor antagonists
SI0973735T1 (en) * 1997-04-10 2003-10-31 Pharmacia & Upjohn Company Polyaromatic antiviral compositions
US6060235A (en) * 1997-09-19 2000-05-09 Geltex Pharmaceuticals, Inc. Antiviral polymers comprising acid functional groups and hydrophobic groups
US6410255B1 (en) * 1999-05-05 2002-06-25 Aurora Biosciences Corporation Optical probes and assays
NZ515675A (en) 1999-05-14 2004-06-25 Nereus Pharmaceuticals Inc Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators
MXPA02002578A (es) 1999-09-08 2002-10-23 Guilford Pharm Inc Compuestos de union a ciclofilina no peptidicos, y su uso.
EP1259608B1 (fr) * 2000-02-23 2009-08-12 Life Technologies Corporation Proteines fluorescentes modifiees
ATE358486T1 (de) * 2000-11-09 2007-04-15 Contrimmune Biotechnology Inc Verwendung von xestospongin c zur behandlung oder vorbeugung einer hiv-infektion
JP4395549B2 (ja) * 2000-11-16 2010-01-13 ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア 薬物及び発酵生成物の発見のための海洋放線菌分類群
CA2435829A1 (fr) 2001-01-25 2002-08-01 Guilford Pharmaceuticals Inc. Composes de liaison de la cyclophiline carboxylique trisubstituee et leur utilisation
US7176232B2 (en) 2002-06-24 2007-02-13 The Regents Of The University Of California Salinosporamides and methods for use thereof
US7112581B2 (en) * 2002-09-27 2006-09-26 Nereus Pharmaceuticals, Inc. Macrocyclic lactams
NZ544858A (en) * 2003-06-20 2009-07-31 Univ California Salinosporamides and methods for use thereof
MXPA05013982A (es) * 2003-06-20 2006-05-25 Nereus Pharmaceuticals Inc Metodos para utilizar compuestos {3.2.0} heterociclicos y sus analogos.
US7727752B2 (en) 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
CA2445420A1 (fr) * 2003-07-29 2005-01-29 Invitrogen Corporation Tests de kinase et de phosphatase
US7619059B2 (en) * 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
KR20060132698A (ko) * 2004-01-23 2006-12-21 니리어스 파마슈티컬즈, 인코퍼레이션 항균제로 유용한 비스-인돌 피롤
AU2005283141B2 (en) 2004-04-30 2012-05-10 Nereus Pharmaceuticals, Inc. (3.2.0) heterocyclic compounds and methods of using the same
US7579371B2 (en) 2004-04-30 2009-08-25 Nereus Pharmaceuticals, Inc. Methods of using [3.2.0] heterocyclic compounds and analogs thereof
MY148329A (en) * 2004-07-05 2013-03-29 Malaysian Palm Oil Board A process for producing oligomers
WO2006060676A1 (fr) * 2004-12-03 2006-06-08 Dana Farber Cancer Institute Compositions et procedes destines au traitement des maladies neoplastiques
WO2007015757A2 (fr) 2005-07-21 2007-02-08 Nereus Pharmaceuticals, Inc. Modulateurs de facteur de necrose tumorale alpha et d'interleukine-1; syntheses de ces modulateurs et procedes d'utilisation de ceux-ci
WO2008095195A2 (fr) * 2007-02-02 2008-08-07 Nereus Pharmaceuticals, Inc. Formulations lyophilisées de salinosporamide a
US20090017167A1 (en) * 2007-07-11 2009-01-15 Herbalife International Inc. Mixture and beverage made therefrom for protecting cellular hydration
US8394816B2 (en) * 2007-12-07 2013-03-12 Irene Ghobrial Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia
WO2009140287A1 (fr) * 2008-05-12 2009-11-19 Nereus Pharmaceuticals, Inc. Dérivés de salinosporamide à utiliser en tant qu'inhibiteurs des protéasomes
JP5588443B2 (ja) 2008-08-19 2014-09-10 クリスオプティクス株式会社 有機化合物の組成物、光学フィルムおよびその製造方法
EP2596390B1 (fr) 2010-07-16 2015-10-07 Crysoptix K.K. FILM OPTIQUE COMPENSATOIRE ET& xA;PROCEDE DE PREPARATION
CN102432871B (zh) * 2011-07-25 2014-03-26 中国科学院长春应用化学研究所 聚脲制备方法
CN106029788B (zh) 2013-10-29 2018-03-06 德司达染料分销有限公司 酸性染料，及其制备方法和应用
EP2868709A1 (fr) 2013-10-29 2015-05-06 DyStar Colours Distribution GmbH Colorants d'acide dépourvus de métaux, procédé pour leur production et leur utilisation
EP2868707A1 (fr) 2013-10-29 2015-05-06 DyStar Colours Distribution GmbH Colorants d'acides sans métaux, procédé pour leur production et utilisation de ces colorants
EP2868715A1 (fr) 2013-10-29 2015-05-06 DyStar Colours Distribution GmbH Colorants d'acide dépourvus de métaux, procédé pour leur production et leur utilisation
EP2868708A1 (fr) 2013-10-29 2015-05-06 DyStar Colours Distribution GmbH Colorants d'acide dépourvus de métaux, procédé pour leur production et leur utilisation
EP2868713A1 (fr) 2013-10-29 2015-05-06 DyStar Colours Distribution GmbH Colorants d'acide dépourvus de métaux, procédé pour leur production et leur utilisation
EP2868703A1 (fr) 2013-10-29 2015-05-06 DyStar Colours Distribution GmbH Colorants d'acide dépourvus de métaux, procédé pour leur production et leur utilisation
EP2868711A1 (fr) 2013-10-29 2015-05-06 DyStar Colours Distribution GmbH Colorants d'acide dépourvus de métaux, procédé pour leur production et leur utilisation
EP2868705A1 (fr) 2013-10-29 2015-05-06 DyStar Colours Distribution GmbH Colorants d'acide dépourvus de métaux, procédé pour leur production et leur utilisation
CN106794986A (zh) 2014-09-02 2017-05-31 布平德尔·辛格 氘化或非氘化分子以及药物制剂
IL312208A (en) 2014-10-08 2024-06-01 Pacific Northwest Res Institute Methods and preparations for increasing the potency of antifungal agents
WO2016062322A1 (fr) * 2014-10-20 2016-04-28 Henkel Ag & Co. Kgaa Détergent préservant les couleurs
EP3209759B1 (fr) * 2014-10-21 2018-12-05 Henkel AG & Co. KGaA Détergent anti-grisaillement
RU2635765C1 (ru) * 2016-10-31 2017-11-15 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Средство, обладающее противовирусной активностью в отношении вируса гриппа
KR101781809B1 (ko) * 2016-12-08 2017-09-27 주식회사 유니피에스 개인 휴대용 단말기의 보안관리용 비닐팩
MX2020010036A (es) 2018-03-28 2021-03-02 Herbalife Int Of America Inc Acetilacion de polisacaridos.
CN110078648B (zh) * 2019-04-25 2021-01-12 上海俪源科技有限公司 一种4,4’-二氨基二磺化二苯砜及其制备方法和应用
US20210330698A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US2833744A (en) * 1953-08-27 1958-05-06 Ciba Pharm Prod Inc Polyureas and process of preparing same
DE1067212B (de) * 1956-06-04 1959-10-15 Farbenfabriken Bayer Aktiengesellschaft, Leverkusen-Bayerwerk Verfahren zur Herstellung von löslichen Polyharnstoffen
CH373467A (de) * 1957-12-23 1963-11-30 Siemens Ag Verfahren zur Prüfung der Beanspruchung von Wechselstromschaltgeräten beim Unterbrechen von Strömen und Anordnung zur Ausübung dieses Verfahrens
US3164571A (en) * 1959-12-31 1965-01-05 Union Carbide Corp Polyureas from n-phenyl, phenylene biscarbamyl halide and a diamine
BE660945A (fr) * 1964-03-12 1965-07-01
US3528949A (en) * 1968-05-07 1970-09-15 Atlas Chem Ind Polymers from ureas and dihalides
FR2105446A5 (en) * 1970-09-07 1972-04-28 Inst Francais Du Petrole Polyamide-imide sulfones - used as cation exchangers and in varnish compsns
US4312855A (en) * 1970-11-16 1982-01-26 Colgate-Palmolive Company Compositions containing aminopolyureylene resin
DE2162963C3 (de) * 1971-12-18 1979-02-01 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von 1,4-Diaminobenzol-2,5-disulfonsäure
US3839294A (en) * 1972-05-01 1974-10-01 Du Pont Sulfonation of diamides of meta-phenylenediamine
FR2212356A1 (en) * 1972-12-29 1974-07-26 Inst Francais Du Petrole Sulphonated imide amide copolymers - used as films membranes, cationic varnishes, ion exchangers, in electrodialysis etc
US3993625A (en) * 1973-05-28 1976-11-23 Toray Industries, Inc. Permselective polymeric membranes of organic polyamide or polyhydrazide
US3978024A (en) * 1973-12-28 1976-08-31 General Electric Company Flame retardant polycarbonate composition
DE2516305A1 (de) * 1975-04-15 1976-10-28 Dynamit Nobel Ag Wasserdispergierbare esterharze
US4107202A (en) * 1977-03-28 1978-08-15 American Cyanamid Company Substituted 4,4'-biphenylylene bis(2-thioureylene)di-naphthalenetrisulfonic acids and salts thereof
GB2001054A (en) * 1977-07-01 1979-01-24 American Cyanamid Co Inhibitors for body fluid proteins
US4756907A (en) * 1978-10-17 1988-07-12 Stolle Research & Development Corp. Active/passive immunization of the internal female reproductive organs
US4389521A (en) * 1979-03-26 1983-06-21 Teijin Limited Process for preparing a cyclic amide polar solvent composition
JPS56147822A (en) * 1980-04-17 1981-11-17 Dainippon Ink & Chem Inc Preparation of novel water-soluble or water-dispersible polyester resin
US4328244A (en) * 1980-05-21 1982-05-04 The Dow Chemical Company Novel (((substituted-phenyl)methyl)amino)benzenesulfonic acids and pharmaceutically-acceptable salts thereof
US4349568A (en) * 1980-06-12 1982-09-14 The Dow Chemical Company Sulfur-substituted diphenyl ethers having antiviral activity
DE3026575A1 (de) * 1980-07-12 1982-02-04 Bayer Ag, 5090 Leverkusen Antitumoral wirkende mittel
US4435394A (en) * 1981-12-17 1984-03-06 Shionogi & Co., Ltd. 3-Sulfonamido-benzophenonimine derivatives useful for treating virus infections
US4471110A (en) * 1982-08-02 1984-09-11 E. I. Dupont De Nemours And Company Polyamide of disulfonated diamine and permselective membrane thereof
DE3345902A1 (de) * 1983-12-20 1985-08-29 Cassella Ag, 6000 Frankfurt In wasser loesliche polymischester, verfahren zu ihrer herstellung und ihre verwendung
US4863735A (en) * 1985-02-19 1989-09-05 Massachusetts Institute Of Technology Biodegradable polymeric drug delivery system with adjuvant activity
US4824916A (en) * 1985-03-15 1989-04-25 The Dow Chemical Company Water-insoluble, crosslinked, sulfonated aromatic polyamide
US4604404A (en) * 1985-04-03 1986-08-05 A. H. Robins Company, Inc. Antiviral sulfonated naphthalene formaldehyde condensation polymers
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
DE3601136A1 (de) * 1986-01-16 1987-07-23 Max Planck Gesellschaft Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren
US4895660A (en) * 1986-07-14 1990-01-23 The Dow Chemical Company Water-soluble aromatic polyamides and polyureas
DE3626309A1 (de) * 1986-08-02 1988-02-18 Stockhausen Chem Fab Gmbh Antivirusmittel
US4897260A (en) * 1987-05-22 1990-01-30 The Rockefeller University Compositions that affect suppression of cutaneous delayed hypersensitivity and products including same
DE3744119A1 (de) * 1987-12-24 1989-07-06 Basf Ag Verwendung von polysulfatierten heparinen
ZA9094B (en) * 1989-01-11 1990-10-31 Merrell Dow Pharma Heparin fraction with anti-hiv activity
JPH0422772A (ja) * 1990-05-16 1992-01-27 Sanden Corp 容量可変型斜板式圧縮機及び斜板
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5124149A (en) * 1990-11-07 1992-06-23 The United States Of America As Represented By The Secretary Of Agriculture Compositions and methods for biocontrol using fluorescent brighteners
FR2669535A1 (fr) * 1990-11-26 1992-05-29 Medgenix Group Sa Utilisation a titre de medicament de macromolecules polysulfonees.
ATE116637T1 (de) * 1991-02-05 1995-01-15 Merrell Dow Pharma Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
EP0626945B1 (fr) * 1992-02-20 1998-04-22 Merrell Pharmaceuticals Inc. Derives d'acide sulfonique utilises dans le traitement de maladies virales
US5460807A (en) * 1992-08-19 1995-10-24 Merrell Dow Pharmaceuticals Inc. Antiproliferative oligomers
US5384119A (en) * 1993-08-12 1995-01-24 Merrell Dow Pharmaceuticals Inc. Method of preventing neutrophil mediated connective tissue damage

Also Published As

Publication number Publication date
RU2102406C1 (ru) 1998-01-20
EP0467185A2 (fr) 1992-01-22
JP3187455B2 (ja) 2001-07-11
US5547992A (en) 1996-08-20
CZ288574B6 (cs) 2001-07-11
HU912299D0 (en) 1991-12-30
SK283655B6 (sk) 2003-11-04
AP9100317A0 (en) 1991-10-31
OA10045A (en) 1996-10-14
ES2124695T3 (es) 1999-02-16
US5670143A (en) 1997-09-23
US5728731A (en) 1998-03-17
IE912375A1 (en) 1992-01-15
EP0467185A3 (en) 1992-09-09
ATE172477T1 (de) 1998-11-15
AU8286791A (en) 1992-02-04
IL98761A0 (en) 1992-07-15
HUT62621A (en) 1993-05-28
HU9300038D0 (en) 1993-04-28
HK1009280A1 (en) 1999-05-28
EP0538373A1 (fr) 1993-04-28
DE69129410T2 (de) 1998-12-03
DE69130381T2 (de) 1999-03-11
US5728874A (en) 1998-03-17
AP287A (en) 1993-10-16
EP0538373A4 (en) 1993-07-21
AU8024291A (en) 1992-01-09
DE69129410D1 (de) 1998-06-18
IL98761A (en) 1995-03-30
US5276182A (en) 1994-01-04
NO930052D0 (no) 1993-01-08
DK0538373T3 (da) 1998-10-12
ES2116295T3 (es) 1998-07-16
US5571505A (en) 1996-11-05
DK0467185T3 (da) 1999-06-28
EG19652A (en) 1995-10-31
CN1058959A (zh) 1992-02-26
NO930052L (no) 1993-03-09
PT98255B (pt) 1998-12-31
NO912672D0 (no) 1991-07-08
NO912672L (no) 1992-01-10
US5707615A (en) 1998-01-13
FI930066A0 (fi) 1993-01-08
EP0467185B1 (fr) 1998-10-21
CS212091A3 (en) 1992-10-14
FI913298A0 (fi) 1991-07-08
CA2086438A1 (fr) 1992-01-10
KR920002662A (ko) 1992-02-28
WO1992000749A1 (fr) 1992-01-23
AU650281B2 (en) 1994-06-16
EP0538373B1 (fr) 1998-05-13
DE69130381D1 (de) 1998-11-26
HU214876B (hu) 1998-07-28
NZ238847A (en) 1994-12-22
JP3442072B2 (ja) 2003-09-02
HUT63561A (en) 1993-09-28
NO302827B1 (no) 1998-04-27
ATE165974T1 (de) 1998-05-15
AU635850B2 (en) 1993-04-01
KR100208547B1 (ko) 1999-07-15
US5606108A (en) 1997-02-25
CN1051096C (zh) 2000-04-05
CA2046491A1 (fr) 1992-01-10
US6232349B1 (en) 2001-05-15
PT98255A (pt) 1992-05-29
MX9100123A (es) 1992-02-28
KR100212336B1 (ko) 1999-08-02
JPH06500535A (ja) 1994-01-20
FI913298A (fi) 1992-01-10
CA2086438C (fr) 2002-03-12
FI930066A (fi) 1993-01-08
HU219229B (en) 2001-03-28
JPH04226521A (ja) 1992-08-17

Similar Documents

Publication Publication Date Title
FI108041B (fi) Menetelmä terapeuttisesti käyttökelpoisten oligomeerien valmistamiseksi
RU2160746C2 (ru) Узкополи- и монодисперсный водорастворимый олигомер, способ его получения, фармацевтический препарат, способ ингибирования активности вирусов
CA2179988C (fr) Formulations pharmaceutiques comportant une polythiouree et procede d'utilisation correspondant
RU2070554C1 (ru) Водорастворимый олигомер и способ его получения
MXPA94005969A (en) Oligomers their uses and formulations
HUT72414A (en) Process for producing oligomeres and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MA Patent expired